首页> 美国卫生研究院文献>The Journal of Neuroscience >Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats
【2h】

Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats

机译:D1-多巴胺受体应答的引发:对新生6-OHDA损伤大鼠重复给药后对D1-多巴胺激动剂的持久行为超敏性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study demonstrates that repeated administration of SKF- 38393, a D1-dopamine agonist, is necessary for maximal behavioral supersensitivity of D1-dopamine receptor responses in neonatal 6-OHDA- lesioned rats, confirming earlier work. This repeated administration of SKF-38393, which is referred to as priming of D1-dopamine receptor responses, resulted in a progressive increase in locomotor activity, as well as several other behaviors. This priming phenomenon lasted at least 6 months. Repeated administration of the D2-dopamine agonist LY- 171555 also increased behavioral responses to the D1-dopamine agonist. However, previous administration of a D2-dopamine agonist was not necessary for priming of D1-dopamine receptor responses, because D1- dopamine receptor priming could be produced in the presence of a D2- dopamine receptor antagonist. Blockade of D1-dopamine receptors with SCH-23390 prior to injection of SKF-38393 prevented the increasing responsiveness following repeated administration of this D1-dopamine agonist. Selective neonatal destruction of dopamine-containing neurons produced the same result as did destruction of catecholamine-containing neurons, indicating that the noradrenergic system is not involved in this phenomenon. Priming of D1-dopamine receptor responses by repeated administration of SKF-38393 was not observed in unlesioned controls or in rats that received catecholamine-depleting lesions as adults. Repeated administration of scopolamine also was able to prime behavioral responses to SKF-38393 in neonatal 6-OHDA-lesioned rats, indicating that endogenous release of dopamine can prime D1-dopamine receptor responses in neonatally lesioned rats. In addition, responses to indirect-acting agonists were enhanced in rats that had been primed with a D1-dopamine agonist when compared wit responses in unprimed animals.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:本研究表明,对于新生的6-OHDA损伤的大鼠,D1-多巴胺受体激动剂SKF- 38393的重复给药对于D1-多巴胺受体应答的最大行为超敏性是必要的,从而证实了早期的工作。 SKF-38393的这种重复给药(称为D1-多巴胺受体应答的引发)导致运动活动和其他几种行为的逐渐增加。这种启动现象至少持续了6个月。重复施用D2-多巴胺激动剂LY-171555也增加了对D1-多巴胺激动剂的行为反应。但是,D1-多巴胺受体激动剂可以在D2-多巴胺受体拮抗剂存在的情况下产生,而D2-多巴胺受体激动剂无需预先给药。在注射SKF-38393之前,用SCH-23390阻断D1-多巴胺受体可防止重复给药此D1-多巴胺激动剂后反应性增加。含多巴胺的神经元的选择性新生儿破坏产生的结果与含儿茶酚胺的神经元的破坏产生相同的结果,表明去甲肾上腺素能系统不参与该现象。在未受损的对照组或成年接受儿茶酚胺消耗性病变的大鼠中,未观察到通过重复施用SKF-38393引发D1-多巴胺受体应答的现象。东碱的重复给药也能够在新生6-OHDA损伤的大鼠中引发对SKF-38393的行为反应,表明内源性多巴胺释放可以在新生损伤的大鼠中引发D1-多巴胺受体反应。此外,与未启动动物相比,用D1-多巴胺激动剂启动的大鼠对间接作用激动剂的响应有所增强(摘要截断为250字)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号